| __timestamp | Exelixis, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 25111000 | 2819557000 |
| Thursday, January 1, 2015 | 37172000 | 4103728000 |
| Friday, January 1, 2016 | 191454000 | 4860427000 |
| Sunday, January 1, 2017 | 452477000 | 5872227000 |
| Monday, January 1, 2018 | 853826000 | 6710800000 |
| Tuesday, January 1, 2019 | 967775000 | 7863400000 |
| Wednesday, January 1, 2020 | 987538000 | 8497100000 |
| Friday, January 1, 2021 | 1434970000 | 16071700000 |
| Saturday, January 1, 2022 | 1611062000 | 12172900000 |
| Sunday, January 1, 2023 | 1830208000 | 13117200000 |
| Monday, January 1, 2024 | 2168701000 | 14202000000 |
Igniting the spark of knowledge
In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success. Over the past decade, Regeneron Pharmaceuticals, Inc. and Exelixis, Inc. have shown remarkable revenue trajectories. From 2014 to 2023, Regeneron has consistently outpaced Exelixis, with its revenue peaking at approximately $13.1 billion in 2023, a staggering 365% increase from 2014. Meanwhile, Exelixis has demonstrated impressive growth, with its revenue surging by over 7,200% during the same period, reaching around $1.83 billion in 2023.
This comparison highlights the competitive nature of the biotech industry, where innovation and strategic partnerships drive financial success. Regeneron's dominance is evident, yet Exelixis's rapid growth underscores its potential to challenge industry leaders. As these companies continue to innovate, their revenue trends offer valuable insights into the future of biotechnology.
Novo Nordisk A/S vs Regeneron Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Comparing Revenue Performance: Johnson & Johnson or Regeneron Pharmaceuticals, Inc.?
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Regeneron Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated or Exelixis, Inc.: Who Leads in Yearly Revenue?
Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Alnylam Pharmaceuticals, Inc. vs Exelixis, Inc.: Examining Key Revenue Metrics
Revenue Insights: Biogen Inc. and Exelixis, Inc. Performance Compared
Exelixis, Inc. and Ionis Pharmaceuticals, Inc.: A Comprehensive Revenue Analysis
Comparing Revenue Performance: Exelixis, Inc. or Arrowhead Pharmaceuticals, Inc.?
Revenue Insights: Exelixis, Inc. and ImmunityBio, Inc. Performance Compared
Exelixis, Inc. vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared